& Springer LLC, a boutique securities class action law firm
focused on representing shareholders nationwide, is investigating
potential breach of fiduciary duty claims against the Board of Directors
of Intermune, Inc. (NASDAQ:ITMN) ("Intermune" or the "Company") relating
to the sale of the Company to Roche. On August 24, 2014, the two
companies announced the signing of a definitive merger agreement
pursuant to which Roche will acquire Intermune in a merger via a tender
offer. As a result of the merger, Intermune shareholders are only
anticipated to receive $74.00 per share in cash in exchange for each
share of Intermune. The deal is worth approximately $8.3 billion.
Andrews & Springer is investigating whether Intermune directors are
breaching their fiduciary duties by failing to adequately shop the
company and maximize shareholder value. Andrews & Springer is also
investigating the fairness of the sales process conducted by Goldman
Sachs and Centerview Partners.
If you own shares of Intermune and want to receive additional
information and protect your investments free of charge, please visit us
or contact Craig J. Springer, Esq. at firstname.lastname@example.org,
or call toll free at 1-800-423-6013. You may also follow us on LinkedIn
Twitter - www.twitter.com/AndrewsSpringer
or Facebook - www.facebook.com/AndrewsSpringer
for future updates.
Andrews & Springer is a boutique securities class action law firm
representing shareholders nationwide who are victims of securities
fraud, breaches of fiduciary duty or corporate misconduct. Having
formerly defended some of the largest financial institutions in the
world, our founding members use their valuable knowledge, experience,
and superior skill for the sole purpose of achieving positive results
for investors. These traits are the hallmarks of our
innovative approach to each case our Firm decides to prosecute. For
more information please visit our website at www.andrewsspringer.com.
This notice may constitute Attorney Advertising.
[ Back To NFVZone's Homepage ]